Compare StocksABBV vs GEHC

AbbVie Inc. (ABBV) vs GE HealthCare Technologies Inc. (GEHC): Which Is the Better Buy in 2026?

As of 2026-06-19, ABBV is overvalued at $216, with a DCF intrinsic value of $160 and a margin of safety of -35%. GEHC is fairly valued at $62, with an intrinsic value of $62 and a margin of safety of 1%. Of the two, GEHC has the wider margin of safety.

ABBV
AbbVie Inc.
$216.49
VS
GEHC
GE HealthCare Technologies Inc.
$61.59

Rewards

ABBV
  • AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Gross margin of 72.0% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
GEHC
  • 8 insider purchases totaling $6.4M with no sells in the past 3 months — insiders are putting their own money in.

Risks

ABBV
  • Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • FCF yield of 5.4% suggests reasonable valuation assuming continued moderate growth.
  • Trailing P/E of 105.6x is 69% above the historical average of 62.3x — the stock trades at a premium to its own history.
GEHC
  • FCF yield of 5.3% suggests reasonable valuation assuming continued moderate growth.

Key Valuation Metrics

Learn more →
ABBV
GEHC
Valuation
$20.81B
Free Cash Flow
$1.48B
5.44%
FCF Yield
5.30%
105.60
Trailing P/E
14.77
13.32
Forward P/E
11.48
Quality & Moat
21.89%
ROIC
8.56%
N/A
ROE
19.46%
72.03%
Gross Margin
39.14%
0.61
PEG Ratio
1.79
Balance Sheet Safety
N/A
Net Debt / Equity
0.76
N/A
Interest Coverage
N/A
2.12
Net Debt / EBITDA
2.36
3.11%
Dividend Yield
0.23%
ABBV: 6Ties: 2GEHC: 2
ABBVGEHC

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

GEHC
No historical data available.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
GEHC
Not enough historical data to compute the retained earnings test.

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
35.3% Overvalued
Price is 35.3% above estimated fair value
Current Price: $216.49
Fair Value: $160.05
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
GEHC
0.7% Margin of Safety
Price is 0.7% below estimated fair value
Current Price: $61.59
Fair Value: $62.02
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

What growth rate is the market pricing in at $216?

+17.1%
Market-Implied Owner Earnings Growth
Standard FCF implies +8.7%

The market implies +17.1% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +8.7%, reflecting heavy growth investment.

GEHC

What growth rate is the market pricing in at $62?

+10.5%
Market-Implied FCF Growth Rate

Economic Moat Score

Learn more →
ABBV
82/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
GEHC

Insufficient data for Economic Moat Score calculation (requires 3+ years).

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
GEHC

Insufficient data for Beneish M-Score calculation (requires 2+ years).

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 76.9%Retail & Other 23.0%
No. of Institutional Holders5,106
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
GEHC
Insiders 0.4%Institutions 93.9%Retail & Other 5.8%
No. of Institutional Holders1,753
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
GEHC
8
Buys (3M)
8
Buys (12M)
Total value (12M): $6.42M
LOBO KEVIN A
Director
$641,800
@ $64.18 · 2026-05-22
HOCHMAN RODNEY F
Director
$100,365
@ $62.03 · 2026-05-12
YANG WATKIN PHOEBE L
Director
$63,006
@ $63.01 · 2026-05-08
CULP HENRY LAWRENCE JR.
Director
$5.00M
@ $61.88 · 2026-05-06
STROMBERG WILLIAM J
Director
$61,689
@ $61.69 · 2026-05-06
SACCARO JAMES
Chief Financial Officer
$200,585
@ $60.60 · 2026-05-01
ARDUINI PETER J
Chief Executive Officer
$249,827
@ $59.92 · 2026-04-30
JIMENEZ FRANK R
General Counsel
$105,788
@ $60.45 · 2026-04-30
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
0
Sells (3M)
5
Sells (12M)
Total value (12M): $21.79M
PURDUE DAVID R.
Officer
$1.22M
@ $233.56 · 2026-03-04
SIATIS PERRY C.
General Counsel
$4.38M
@ $234.39 · 2026-03-02
SIATIS PERRY C.
General Counsel
$5.15M
@ $230.00 · 2026-02-25
SALEKI-GERHARDT AZITA
Chief Operating Officer
$8.41M
@ $198.42 · 2025-08-12
DONOGHOE NICHOLAS
Officer
$2.64M
@ $198.51 · 2025-08-05
STEWART JEFFREY RYAN
Officer
$12.36M
@ $210.08 · 2025-03-31
REENTS SCOTT T.
Chief Financial Officer
$3.75M
@ $212.34 · 2025-03-14
GONZALEZ RICHARD A
Director
$20.26M
@ $205.45 · 2025-03-03
SIATIS PERRY C.
General Counsel
$5.82M
@ $208.69 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$4.47M
@ $210.45 · 2025-03-03
BUCKBEE KEVIN K
Officer
$3.85M
@ $203.41 · 2025-02-26
RICHMOND TIMOTHY J
Officer
$6.07M
@ $202.90 · 2025-02-26
SIATIS PERRY C.
General Counsel
$1.14M
@ $197.90 · 2025-02-20
BUCKBEE KEVIN K
Officer
$310,032
@ $172.24 · 2024-12-16
GONZALEZ RICHARD A
Officer and Director
$12.40M
@ $186.52 · 2024-08-05
GONZALEZ RICHARD A
Officer and Director
$49.50M
@ $175.00 · 2024-07-17
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
GEHC
0
Sells (3M)
0
Sells (12M)
NEWCOMB GEORGE A.
Officer
$185,080
@ $92.54 · 2025-02-18
ROTT ROLAND
Officer
$309,339
@ $86.48 · 2024-11-06
RACKLIFFE PHILIP
Chief Executive Officer
$78,867
@ $87.63 · 2024-11-05
STACHERSKI KENNETH ROBERT
Officer
$1.58M
@ $83.22 · 2024-08-14
WESTRICK THOMAS J
Officer
$222,145
@ $80.78 · 2024-08-07
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😐Neutral(56/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
GEHC
FearGreed
😨Fear(37/100)

"Market is pessimistic — investigate whether fears are temporary or structural"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (56)
GEHC
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Fear (37)
View ABBV Full AnalysisView GEHC Full Analysis

Frequently Asked Questions: ABBV vs GEHC

Is AbbVie Inc. or GE HealthCare Technologies Inc. more undervalued in 2026?

Based on our discounted cash flow model, GEHC trades at a 0.7% margin of safety (intrinsic value $62 vs. price $62), compared to ABBV's -35.3% margin of safety (intrinsic $160 vs. $216).

Which company has better free cash flow, AbbVie Inc. or GE HealthCare Technologies Inc.?

AbbVie Inc. (ABBV) generates a 5.4% free cash flow yield, compared to GE HealthCare Technologies Inc.'s 5.3%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

Which stock has higher return on invested capital, AbbVie Inc. or GE HealthCare Technologies Inc.?

ABBV earns 21.9% ROIC versus GEHC's 8.6%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.